Sign in

CIK 0001711279

  • Large accelerated filer

Krystal Biotech, Inc.

Sign in to watch
Ticker
KRYS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
821080209
Phone
+1 412-586-5830
Business address
2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$17,966,069
in 2 filings, $18.0M under 10b5-1 plans

Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-06-09 ORTH ANDREW C. Chief Commercial Officer Exercise or conversion 10b5-1 +12,500 $63.55 $794K 12,600
2023-06-09 ORTH ANDREW C. Chief Commercial Officer Sale 10b5-1 −5,261 $128.10 $674K 7,339
2023-06-09 ORTH ANDREW C. Chief Commercial Officer Sale 10b5-1 −6,906 $128.94 $890K 433
2023-06-09 ORTH ANDREW C. Chief Commercial Officer Sale 10b5-1 −333 $129.70 $43K 100
2023-06-09 ORTH ANDREW C. Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −12,500 37,500
2023-02-28 ORTH ANDREW C. Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +20,000 20,000
2023-02-28 ORTH ANDREW C. Chief Commercial Officer Grant or award · Performance Stock Units +10,000 10,000
2022-02-28 ORTH ANDREW C. Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2021-05-31 ORTH ANDREW C. Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +205,000 205,000

Page 1 of 1 · 9 trades